These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18049369)

  • 1. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P; Cherry JD
    Pediatr Res; 2007 Nov; 62(5):527. PubMed ID: 18049369
    [No Abstract]   [Full Text] [Related]  

  • 2. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV vaccine: beyond the hype.
    Consum Rep; 2007 Oct; 72(10):47. PubMed ID: 17912799
    [No Abstract]   [Full Text] [Related]  

  • 4. The quadrivalent human papillomavirus vaccine.
    Wheat A
    Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?
    Covell JL; Stoler MH
    Am J Clin Pathol; 2007 Nov; 128(5):726-8. PubMed ID: 17951192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diseases caused by human papilloma viruses].
    Zollner U; Schwarz TF
    Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pediatrician's role in preventing cervical cancer.
    Blatter MM; Monk BJ
    Clin Pediatr (Phila); 2008 Sep; 47(7):627-38. PubMed ID: 18698095
    [No Abstract]   [Full Text] [Related]  

  • 9. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
    Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E
    Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
    Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
    Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
    Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ
    Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849
    [No Abstract]   [Full Text] [Related]  

  • 17. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debate begins over public funding for HPV vaccine.
    Comeau P
    CMAJ; 2007 Mar; 176(7):913-4. PubMed ID: 17374749
    [No Abstract]   [Full Text] [Related]  

  • 19. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 20. Genital condylomata are not the human papilloma virus male infection burden.
    Bartoletti R; Zizzo G; Cai T; Mirone V
    Eur Urol; 2011 Aug; 60(2):268-9. PubMed ID: 21550167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.